Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000331606 | SCV000372452 | uncertain significance | Fetal akinesia deformation sequence 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000386023 | SCV000372453 | uncertain significance | Congenital Myasthenic Syndrome, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001859810 | SCV002210400 | uncertain significance | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 236 of the RAPSN protein (p.Ala236Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs545915312, ExAC 0.003%). This variant has not been reported in the literature in individuals with RAPSN-related conditions. ClinVar contains an entry for this variant (Variation ID: 304975). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003129829 | SCV003813734 | uncertain significance | not provided | 2023-09-23 | criteria provided, single submitter | clinical testing |